Related Experiment Video
Updated: Aug 15, 2026

Detection of Toxin Translocation into the Host Cytosol by Surface Plasmon Resonance
Published on: January 3, 2012
Involvement of domain II in toxicity of anthrax lethal factor
Xudong Liang1, John J Young, Sherrie A Boone
1Laboratory of Cancer and Developmental Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan 49503, USA.
Abstract:
Anthrax lethal factor (LF) is a Zn2+ -metalloprotease that cleaves and inactivates mitogen-activated protein kinase kinases (MEKs). We have used site-directed mutagenesis to identify a cluster of residues in domain II of LF that lie outside the active site and are required for cellular proteolytic activity toward MEKs. Alanine substituted for Leu293, Lys294, Leu514, Asn516, or Arg491 caused a 10-50-fold reduction in LF toxicity. Further, whereas pairwise substitution of alanine for Leu514 and either Leu293, Lys294, or Arg491 completely abrogated LF toxicity, pairwise mutation of Leu514 and Asn516 resulted in toxicity comparable with N516A alone. The introduction of these mutations reduced LF-mediated cleavage of MEK2 in cell-based assays but altered neither the ability of LF to bind protective antigen nor its ability to translocate across a membrane. Interestingly, direct in vitro measurement of LF activity indicated that decreased toxicity was not always accompanied by reduced proteolytic activity. However, mutations in this region significantly reduced the ability of LF to competitively inhibit B-Raf phosphorylation of MEK. These results provide evidence that elements of domain II are involved in the association of LF into productive complex with MEKs.
Insights
Anthrax lethal factor (LF) mutations outside its active site reduce toxicity by impairing MEK binding. These findings reveal domain II
Area of Science:
- Biochemistry
- Molecular Biology
- Toxicology
Background:
- Anthrax lethal factor (LF) is a toxic metalloprotease.
- LF cleaves and inactivates mitogen-activated protein kinase kinases (MEKs).
- Understanding LF's mechanism is crucial for developing countermeasures.
Purpose of the Study:
- To identify residues in LF domain II critical for MEK cleavage.
- To investigate the role of these residues in LF's cellular activity and toxicity.
Main Methods:
- Site-directed mutagenesis of specific LF residues (Leu293, Lys294, Leu514, Asn516, Arg491).
- Assessment of LF toxicity in cell-based assays.
- Measurement of MEK2 cleavage and B-Raf phosphorylation inhibition in vitro.
Main Results:
- Mutations outside the LF active site, particularly in domain II, significantly reduced LF toxicity (10-50 fold).
- Specific pairwise mutations abrogated LF toxicity, while others showed partial reduction.
- Mutations impaired LF-mediated MEK2 cleavage and B-Raf phosphorylation inhibition but not LF binding or translocation.
Conclusions:
- Residues in LF domain II, outside the active site, are essential for productive interaction with MEKs.
- These domain II elements are involved in LF's association with MEKs, impacting cellular activity.
- The findings provide insights into LF's mechanism of action and potential therapeutic targets.
More Related Videos
09:30Analyzing Dynamic Protein Complexes Assembled On and Released From Biolayer Interferometry Biosensor Using Mass Spectrometry and Electron Microscopy
Published on: August 6, 2018
08:17Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
Published on: October 28, 2022
Related Concept Videos
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Fungal Phylum Basidiomycota
Bacterial Toxins
Regulation of Bacterial Virulence
Inhalation Anthrax
Diphtheria